Clinical Trial Update: Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating either long-course chemoradiotherapy or short-course radiotherapy combined with CAPOX, a PD-1 antibody, and a COX-2 inhibitor for MSS l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Celecoxib (Celecoxib)
• OXALIPLATIN (Oxaliplatin)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Fudan University | Conditions: Locally Advanced Rectal Cancer, Neoadjuvant Therapy | Phase 2 | Status: RECRUITING